Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly Whomps Novo Nordisk
Eli Lilly’s Zepbound Beats Novo Nordisk’s Wegovy in First Head-to-Head Study
People who took Zepbound lost 17 pounds more on average after 72 weeks of treatment than those who were given Novo Nordisk’s drug.
Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial
Eli Lilly's popular weight-loss drug Zepbound outperformed Danish drugmaker Novo Nordisk's Wegovy in a clinical trial, according results of the study released Wednesday.
Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly.
3d
Lilly's Zepbound tops Wegovy for weight loss in head-to-head trial
Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo ...
1d
Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup
Some patients taking weight-loss drugs, including popular GLP-1 treatments like Ozempic (NVO) and Wegovy, reported reducing ...
STAT
3d
Pharmalittle: We’re reading about a Zepbound-Wegovy faceoff, compounders slamming Novo, and more
Eli Lilly said its weight loss drug Zepbound led to 47% greater weight reduction than rival medicine Wegovy, made by Novo ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
SK pres avoids impeachment
Manslaughter dropped
Wins Grand Prix Final
$965 million verdict upheld
Ruby slippers sell for $28M
To run for top Democrat
Threat prompts evacuation
Murder suspect recaptured
‘Dynasty' actor dies at 77
Trump on Syria conflict
PA grandmother found dead
$988M aid package for UKR
Producer Maslansky dies
Syrian rebels take Homs
NY museum unveils 'Apex'
Chinese vessel hijacked
Chipotle raising US prices
Taking extended leave
NFL ends Watson probe
Drops bid for third term
Family awarded $310 million
Havana syndrome report
Messi wins MLS MVP award
Climbers feared dead
AI bias meter coming
Oven gloves recalled
Hired as Utah State coach
WHO probes Congo disease
Fined $25K for gesture
CFPB sues Comerica Bank
Romanian election annulled
Feedback